Comment
doi: 10.1016/S1474-4422(20)30353-7.
Epub 2020 Oct 23.
High-dose biotin in multiple sclerosis: the end of the road
Affiliations
- PMID: 33222766
- DOI: 10.1016/S1474-4422(20)30353-7
Item in Clipboard
Comment
High-dose biotin in multiple sclerosis: the end of the road
Lancet Neurol.
2020 Dec.
No abstract available
Comment on
-
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Neurol. 2020 Dec;19(12):988-997. doi: 10.1016/S1474-4422(20)30347-1. Epub 2020 Oct 23. Lancet Neurol. 2020. PMID: 33222767 Clinical Trial.
Similar articles
-
Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis.Expert Opin Drug Metab Toxicol. 2016;12(3):327-44. doi: 10.1517/17425255.2016.1136288. Epub 2016 Feb 17. Expert Opin Drug Metab Toxicol. 2016. PMID: 26699811 Review.
-
Biotin supplementation in MS clinically valuable but can alter multiple blood test results.Mult Scler. 2017 Apr;23(4):619-620. doi: 10.1177/1352458516680751. Epub 2016 Dec 7. Mult Scler. 2017. PMID: 27899554 No abstract available.
-
Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis.J Endocrinol Invest. 2017 Aug;40(8):889-890. doi: 10.1007/s40618-017-0678-y. Epub 2017 May 6. J Endocrinol Invest. 2017. PMID: 28478548 No abstract available.
-
[Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin use].Ned Tijdschr Geneeskd. 2018 Feb 14;162:D2358. Ned Tijdschr Geneeskd. 2018. PMID: 30730120 Dutch.
-
The use of cyclophosphamide to treat multiple sclerosis.Clin Neuropharmacol. 1987 Apr;10(2):155-61. doi: 10.1097/00002826-198704000-00005. Clin Neuropharmacol. 1987. PMID: 3332608 Review. No abstract available.
Cited by
-
Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives.Int J Mol Sci. 2024 Jun 14;25(12):6578. doi: 10.3390/ijms25126578. Int J Mol Sci. 2024. PMID: 38928282 Free PMC article. Review.
-
Nutritional interventional studies in patients with multiple sclerosis: a scoping review of the current clinical evidence.J Neurol. 2024 Apr;271(4):1536-1570. doi: 10.1007/s00415-023-12140-z. Epub 2024 Jan 4. J Neurol. 2024. PMID: 38177875 Review.
-
Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesions.Nat Metab. 2023 Aug;5(8):1364-1381. doi: 10.1038/s42255-023-00838-3. Epub 2023 Jul 10. Nat Metab. 2023. PMID: 37430025 Free PMC article.
-
Macronutrients, vitamins and minerals in the diet of multiple sclerosis patients.Postep Psychiatr Neurol. 2022 Sep;31(3):128-137. doi: 10.5114/ppn.2022.121730. Epub 2022 Nov 29. Postep Psychiatr Neurol. 2022. PMID: 37082222 Free PMC article. Review.
-
Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.J Neuroinflammation. 2022 Feb 10;19(1):45. doi: 10.1186/s12974-022-02408-y. J Neuroinflammation. 2022. PMID: 35144628 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
